Rigel Says Breast Cancer Drug Veppanu Now Available in US, Puerto Rico

RegulatoryapprovedVeppanuPositive

AI Analysis

Summary

Rigel Pharmaceuticals announced that Veppanu, a breast cancer drug, is now available in the United States and Puerto Rico. This marks a regulatory achievement with commercial availability.

Outcome Details

Veppanu now available in US and Puerto Rico

Importance:7/10

Sentiment:

0.70

FDA approvaloncologycommercial launchUS market

Related Companies

$RIGL

Read the original article

Published by yahoo_finance on August 13, 2026 1:42 PM

Read Original